Class II · Moderate risk Terminated
Syphilinum
Reason cGMP deviations
FDA Drug Recalls
11,815 recalls · Class II, newest first
Class II · Moderate risk Terminated
Streptococcinum
Reason cGMP deviations
Class II · Moderate risk Terminated
Pyrogenium
Reason cGMP deviations
Class II · Moderate risk Terminated
Proteus
Reason cGMP deviations
Class II · Moderate risk Terminated
Pertussinum
Reason cGMP deviations
Class II · Moderate risk Terminated
Morbillinum
Reason cGMP deviations
Class II · Moderate risk Terminated
Medorrhinum
Reason cGMP deviations
Class II · Moderate risk Terminated
Influenzinum
Reason cGMP deviations
Class II · Moderate risk Terminated
Diphtherinum
Reason cGMP deviations
Class II · Moderate risk Terminated
Colibacillinum
Reason cGMP deviations
Class II · Moderate risk Terminated
Candida Parapsilosis
Reason cGMP deviations
Class II · Moderate risk Terminated
Candida Albicans
Reason cGMP deviations
Class II · Moderate risk Terminated
Bacillinum Pulmo
Reason cGMP deviations
Class II · Moderate risk Terminated
Anthracinum
Reason cGMP deviations
Class II · Moderate risk Terminated
Zonisamide Capsules USP
Reason CGMP Deviations: Gaps in the quality system in the Quality Control microbiology laboratory.
Class II · Moderate risk Terminated
Losartan Pot/HCTZ 100/25 mg 90 Tabs NDC 72189-289-90 Packaged and…
Reason CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits .
Class II · Moderate risk Terminated
Losartan Pot/HCTZ 50/12.5 mg 90 Tabs NDC 72189-297-90 Packaged…
Reason CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits .
Class II · Moderate risk Terminated
Losartan Pot/HCTZ 100/12.5 mg 90 Tabs NDC 72189-290-90 Packaged…
Reason CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits .
Class II · Moderate risk Terminated
medroxyPROGESTERone Acetate Injectable Suspension
Reason Lack of assurance of sterility
Class II · Moderate risk Terminated
medroxyPROGESTERone Acetate Injectable Suspension
Reason Lack of assurance of sterility
Class II · Moderate risk Terminated
medroxyPROGESTERone Acetate Injectable Suspension
Reason Lack of assurance of sterility
Class II · Moderate risk Terminated
medroxyPROGESTERone Acetate Injectable Suspension
Reason Lack of assurance of sterility
Class II · Moderate risk Terminated
medroxyPROGESTERone Acetate Injectable Suspension
Reason Lack of assurance of sterility
Class II · Moderate risk Terminated
Losartan Pot./HCTZ 100/12.5 mg Packaged and Distributed By…
Reason CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Class II · Moderate risk Terminated
Equate Tartar Control Plus
Reason Superpotent Drug: product complaint for milky blue appearance and consistency, further investigation by the firm found the recalled lots out of specification for the four active ingredients.